Physician profile
Robert Picciano
NPI 1841210861
$447.51
in general payments reported to CMS, 2019-2025
10 companies · $41.12 in 2025
The $41.12 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $44.08 · 2022: $39.13 · 2023: $50.78 · 2024: $81.39 · 2025: $41.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $179.42 | 2019-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $62.22 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $44.12 | 2019 | |
| Amgen INC. | $32.61 | 2024 | Otezla, Repatha |
| E.R. Squibb & Sons, L.L.C. | $28.86 | 2023 | Eliquis |
| Pfizer INC. | $27.13 | 2019 | |
| Dexcom, INC. | $21.92 | 2023 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $17.91 | 2025 | Nucala |
| Lilly USA, LLC | $17.88 | 2024 | Mounjaro, Zepbound |
| Mylan Specialty L.P. | $15.44 | 2024 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Picciano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.